ArticleParasites & vectors2025
RNA interference mediated mortality in Aedes albopictus: a challenging journey toward species-specific vector control.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundAedes albopictus is a major vector of pathogens, including arboviruses, causing thousands of deaths annually. With no effective antiviral therapies and increasing concerns about the ecological impact of chemical insecticides, species-specific strategies, such as RNA interference (RNAi), are beneficial. Thus, identifying and validating target genes that induce mortality is essential. However, RNAi efficacy in Ae. albopictus is often inconsistent, owing to multiple factors including degradation by nucleases. Therefore, molecular identification and quantification of the underlying nucleases will provide a basis for improving RNAi efficacy.
methodsTarget genes were selected from previous studies, identified in Ae. albopictus, and their corresponding long double-stranded RNAs (dsRNAs) were designed. Using U4.4. cells as a first model, cytotoxicity was assessed with the CellTiter-Glo assay and gene knockdown via RT-qPCR. Larval survival assays and RT-qPCR were then used to evaluate in vivo effects. Owing to the lack of significant larval mortality, dsRNA complex size was analyzed using dynamic light scattering and their oral uptake was visualized by fluorescence microscopy. Suspecting degradation, dsRNA stability was assessed by agarose gel electrophoresis following incubation with larval gut extracts. This prompted the identification, characterization, and validation of two putative dsRNases. Finally, transfection reagents (TRs) were tested for their ability to protect dsRNA from degradation.
resultsOnly one of the synthesized dsRNAs targeting the inhibitor of apoptosis (IAP) significantly reduced U4.4 cell viability to 65% (uncomplexed-dsRNA) and 13% (K4-complexed dsRNA). However, all tested dsRNAs achieved significant gene knockdown in the cell-based assay. None of the dsRNAs induced significant larval mortality, because dsRNA was rapidly degraded by larval gut extracts within 4 min. Although, gene knockdown was confirmed in the gut tissue. Each of the two identified dsRNases contained a signal peptide, catalytic residues, and substrate- and Mg
conclusionsAll target genes were significantly silenced in cells, and IAP in larval gut tissue. Although TRs improved dsRNA stability in vitro, no significant larval mortality was observed, likely due to rapid gut degradation. Therefore, effective RNAi-based control of Ae. albopictus requires identifying gut-specific essential genes and improved delivery systems.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.